A systematic review on anti-diabetic plant essential oil compounds: Dietary sources, effects, molecular mechanisms,

Gopalsamy Rajiv Gandhi1, Varghese Edwin Hillary1, Poovathumkal James Antony2

  • 1Division of Phytochemistry and Drug-Design, Department of Biosciences, Rajagiri College of Social Sciences (Autonomous), Kochi, India.

Insights

Essential oils from dietary plants show potent anti-diabetic effects by targeting insulin resistance and inflammation. These natural compounds offer a safe and beneficial approach to managing type 2 diabetes mellitus (T2DM) and its complications.

Area of Science:

  • Pharmacology and Toxicology
  • Metabolic Disorders
  • Natural Product Chemistry

Background:

  • Type 2 diabetes mellitus (T2DM) is a complex metabolic syndrome characterized by insulin resistance and pancreatic beta-cell dysfunction.
  • Inflammation, mediated by interleukins, significantly contributes to T2DM progression.
  • Essential oils from dietary plants are recognized for their therapeutic potential in chronic diseases.

Purpose of the Study:

  • To review the anti-diabetic properties of essential oil compounds derived from dietary plants.
  • To elucidate the molecular mechanisms underlying their effects on insulin resistance and glucose metabolism.
  • To assess their safety and efficacy based on recent literature.

Main Methods:

  • A comprehensive literature search was conducted in Scopus, Web of Science, PubMed, and Embase databases.
  • Studies published between 2010 and 2022 focusing on dietary plants, essential oils, and anti-diabetic mechanisms were included.
  • Keywords included 'dietary plants,' 'essential oils,' 'anti-diabetic,' 'insulin resistance,' and 'T2DM.'

Main Results:

  • Specific essential oil compounds (e.g., cinnamaldehyde, carvacrol, thymol) demonstrated significant anti-diabetic effects by modulating key signaling pathways (AMPK, PPARγ, NF-κB).
  • These compounds reduced inflammatory markers (TNF-α, IL-6) and oxidative stress (TBARS, MDA) in animal models.
  • Improvements were observed in insulin levels, antioxidant enzyme activity (SOD, CAT), and lipid profiles.

Conclusions:

  • Dietary plant-derived essential oil compounds possess significant potential for managing T2DM through diverse molecular targets.
  • Their ability to modulate glucose metabolism, reduce inflammation, and combat oxidative stress highlights their therapeutic value.
  • Most reviewed essential oil compounds appear safe, suggesting promising applications in diabetes treatment and complication prevention.

Related Concept Videos

Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
204
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
232
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
253
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
326
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K